Application of nanoscale metal–organic frameworks in tumor immunotherapy
Rare Metals · 2024-10 · 43 (10) · 4867-4883
DOI: 10.1007/s12598-024-02779-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rare Metals, online erschienen am 18.06.2024. Verfasst von Xiao‐Xuan Zeng und 7 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 129 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Gui Style Xinglin Top Talent Funding Project of Guangxi University of Chinese Medicine, Young and Middle-aged Backbone Teachers Training Project of Guangxi Colleges and Universities.
Abstract (Originalsprache)
Immunotherapy has attracted wide attention because it can not only kill tumor cells but also effectively prevent tumor recurrence. However, due to the poor efficacy of the monotherapy in tumor immunotherapy, combination therapies are needed to enhance their efficacy, such as chemodynamic therapy/immunotherapy, photodynamic therapy/immunotherapy, sonodynamic therapy/immunotherapy and so on. Nanoscale metal–organic frameworks (nMOFs) are widely used for drug delivery because of their rich and variable composition, high drug loading capacity and good biodegradability. Compared with other conventional drug delivery systems (DDSs), nMOFs play more advantageous role in inducing immune cell death of tumor cells and combination therapies. This article focuses on the application of nMOFs in tumor immunotherapy in terms of their use as gatekeepers, supplementary agents and drug carriers, respectively, with the aim of providing some ideas and references for the design of smart nanoscale DDS for tumor immunotherapy.
Förderung
- National Natural Science Foundation of China
- Gui Style Xinglin Top Talent Funding Project of Guangxi University of Chinese Medicine
- Young and Middle-aged Backbone Teachers Training Project of Guangxi Colleges and Universities
- Innovation Project of Guangxi Graduate Education
Zitieren
APA
Zeng, X., Lu, J., Ma, D., Huang, Y., Chen, L., Wang, G., Chen, Q., & Lin, N. (2024). Application of nanoscale metal–organic frameworks in tumor immunotherapy. Rare Metals, 43(10), 4867-4883. https://doi.org/10.1007/s12598-024-02779-6
Vancouver
Zeng X, Lu J, Ma D, Huang Y, Chen L, Wang G, et al. Application of nanoscale metal–organic frameworks in tumor immunotherapy. Rare Metals. 2024;43(10):4867-4883. doi:10.1007/s12598-024-02779-6
BibTeX
@article{Zeng2024,
author = {Zeng, Xiao‐Xuan and Lu, Jing‐Sheng and Ma, Dong‐Wei and Huang, Yu‐Ting and Chen, Ling and Wang, Gang and Chen, Qing and Lin, Ning},
title = {Application of nanoscale metal–organic frameworks in tumor immunotherapy},
journal = {Rare Metals},
year = {2024},
volume = {43},
number = {10},
pages = {4867--4883},
doi = {10.1007/s12598-024-02779-6}
}
EUVIMED